TickerFactsScreenerDevelopers

Korro Bio, Inc. (KRRO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $42.19M2019: $200.16M2020: $220.34M2021: $79.64M2022: $36.33M2023: $166.15M2024: $55.64M2025: $21.82M$21.82M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$21.82M-60.8%
2024$55.64M-66.5%
2023$166.15M+357.3%
2022$36.33M-54.4%
2021$79.64M-63.9%
2020$220.34M+10.1%
2019$200.16M+374.4%
2018$42.19M—